Tradestie Institutional Equity Comparison Engine

QLTI vs ALKS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ALKS Overall Edge

ALKS Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alkermes Inc. plc (ALKS) driven by superior Valuation, Growth & Margin, Options & Structure while QLTI counters with relative strength in Momentum & Technical. Fundamentally, QLTI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ALKS at 133.3x Forward P/E and 11.5% operating margin (+21.8% YoY). In options structure, QLTI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ALKS sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ALKS
QLTI N/M vs ALKS 133.3x Fwd P/E
Growth & Margin Winner ALKS
Op Margin N/A vs 11.5% ยท YoY N/A vs +21.8%
Momentum & Technical Winner QLTI
1Y +7.0% vs +50.0% ยท 52W Pos 86% vs 68%
Options & Structure Winner ALKS
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (6th %ile IV)
QLTI NYSE Arca
GMO International Quality ETF
Institutional Equity
$28.11
-0.81% 1D
Market Cap N/A
1M Return +2.85%
1Y Return +6.95%
Forward P/E N/M
Unified AI Score
47.8 / 100 HOLD
Tech 50.0 Fund 35.0 Flow 50.0 Mom 11.1
ALKS NASDAQ
Alkermes Inc. plc
Pharmaceutical Preparations
$46.53
-1.06% 1D
Market Cap $7.9B
1M Return +12.88%
1Y Return +50.05%
Forward P/E 133.3x
Unified AI Score
32.1 / 100 SELL
Tech 16.0 Fund 39.0 Flow 68.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: QLTI +6.95% ALKS +50.05% Spread: +41.98 pp (ALKS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
QLTI TTM Op. Margin: N/A ALKS TTM Op. Margin: 11.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on QLTI vs ALKS. Trailing 12-month operating profitability (QLTI N/A vs ALKS 11.5%) and valuation multiples (QLTI N/M vs ALKS 133.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: QLTI (3) vs ALKS (7)
Institutional Metric QLTI ALKS Criterion Row Winner
Market Capitalization Scale N/A $7.9B Larger Scale ALKS
Trailing P/E Ratio Valuation N/M 133.3x Lower Multiple ALKS
Forward P/E Ratio Valuation N/M 133.3x Lower Multiple ALKS
Revenue Growth (YoY) Growth N/A +21.8% Higher Growth ALKS
Operating Margin (TTM) Profitability N/A 11.5% Higher Margin ALKS
Net Profit Margin Profitability N/A -0.0% Higher Margin ALKS
Return on Equity (ROE) Capital Efficiency N/A -0.0% Higher ROE ALKS
52-Week Range Position Momentum 86% ($24โ€“$29) 68% ($27โ€“$56) Stronger Trend QLTI
Beta / 30D Volatility Risk Regime 0.81ฮฒ ยท 16% Vol 0.75ฮฒ ยท 26% Vol Lower Realized Risk QLTI
Unified Institutional Score Composite Signal 47.8 / 100 (HOLD) 32.1 / 100 (SELL) Higher Composite QLTI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full QLTI vs ALKS Buy Guide
QLTI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live QLTI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ALKS CONSOLIDATION
101d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ALKS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither QLTI nor ALKS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.